Devazepide

Devazepide

Clinical data
ATC code	none
Identifiers
IUPAC name N-(1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl)-1H-indole-2-carboxamide
CAS Number	103420-77-5 Y
PubChem CID	443375
IUPHAR/BPS	878
ChemSpider	391607 N
UNII	JE6P7QY7NH
KEGG	D02693 Y
ChEMBL	CHEMBL9506 N
ECHA InfoCard	100.208.547
Chemical and physical data
Formula	C25H20N4O2
Molar mass	408.452 g/mol
3D model (JSmol)	Interactive image
SMILES O=C(c2cc1ccccc1n2)N[C@H]3/N=C(\c4ccccc4N(C3=O)C)c5ccccc5
InChI InChI=1S/C25H20N4O2/c1-29-21-14-8-6-12-18(21)22(16-9-3-2-4-10-16)27-23(25(29)31)28-24(30)20-15-17-11-5-7-13-19(17)26-20/h2-15,23,26H,1H3,(H,28,30)/t23-/m1/s1 N Key:NFHRQQKPEBFUJK-HSZRJFAPSA-N N
NY (what is this?)

Devazepide (L-364,718, MK-329) is benzodiazepine drug, but with quite different actions from most benzodiazepines, lacking affinity for GABA_A receptors and instead acting as an CCK_A receptor antagonist. It increases appetite and accelerates gastric emptying, and has been suggested as a potential treatment for a variety of gastrointestinal problems including dyspepsia, gastroparesis and gastric reflux. It is also widely used in scientific research into the CCK_A receptor.

Devazepide is synthesised in a similar manner to other benzodiazepines.